TriMas (TRS)
(Delayed Data from NSDQ)
$24.70 USD
-0.15 (-0.60%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $24.71 +0.01 (0.04%) 5:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.70 USD
-0.15 (-0.60%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $24.71 +0.01 (0.04%) 5:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Zacks News
Timken (TKR) Shares Decline 7% Despite Q2 Earnings Beat
by Zacks Equity Research
Timken (TKR) expects adjusted EPS of $6.00-$6.20 for 2024 compared with the prior stated $6.00-$6.30.
TriMas (TRS) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
TriMas' (TRS) Q2 top line reflects growth in the packaging and aerospace segments, offset by a decline in the Specialty Products segment.
TriMas (TRS) Q2 Earnings Miss Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of -18.87% and 3.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
GrafTech International (EAF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrafTech (EAF) delivered earnings and revenue surprises of 54.55% and 12.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Kaiser Aluminum (KALU) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kaiser (KALU) delivered earnings and revenue surprises of -30.85% and 2.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion
by Zacks Equity Research
Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion are part of the Zacks Market Edge blog.
5 Top Small Cap Stocks to Buy Now
by Tracey Ryniec
How to screen for the best small cap stocks using the Zacks Rank.
Down -5.13% in 4 Weeks, Here's Why You Should You Buy the Dip in TriMas (TRS)
by Zacks Equity Research
The heavy selling pressure might have exhausted for TriMas (TRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Why Is Century (CENX) Up 18.1% Since Last Earnings Report?
by Zacks Equity Research
Century (CENX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Timken (TKR) Tops Q1 Earnings Estimates, Raises '24 View
by Zacks Equity Research
Timken (TKR) witnesses year-over-year declines in Q1 revenues and earnings from the record levels reported last year due to low volumes.
TriMas (TRS) Q1 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
TriMas' (TRS) Q1 top and bottom lines reflect organic growth in both aerospace and packaging segments.
Weakness in Specialty Products, High Costs Ail TriMas (TRS)
by Zacks Equity Research
TriMas' (TRS) results will bear the brunt of the recent weakness in industrial cylinder demand, as well as high costs and labor shortages.
TriMas (TRS) Earnings Miss Estimates in Q4, Revenues Rise Y/Y
by Zacks Equity Research
TriMas' (TRS) Q4 top line reflects organic growth in the aerospace and defense business.
ESAB Corporation (ESAB) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Esab (ESAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ESAB Corporation (ESAB) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Esab (ESAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is TriMas (TRS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy AB SKF (SKFRY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas
by Zacks Equity Research
Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas
5 Metal Fabrication Stocks to Watch in a Challenging Industry
by Madhurima Das
Low order levels cloud the near-term prospects of the Zacks Metal Products - Procurement and Fabrication industry. However, the likes of NHYDY, SKFRY, ESAB, CENX and TRS seem well-poised to tide over the hurdles.
TriMas (TRS) Expands Life Sciences' Cleanroom Capabilities
by Zacks Equity Research
TriMas (TRS) expands the cleanroom capabilities of its Life Sciences division as part of its long-term strategic enhancement.
TriMas (TRS) Stock Down 7% in a Year: Will It Bounce Back in 2024?
by Zacks Equity Research
TriMas' (TRS) results and price performance have been mirroring the persisting weakness in packaging demand, escalating raw material costs and supply-chain constraints.
Timken (TKR) Up 2.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Timken (TKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 1.79% and 4.77%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?